WOODCLIFF LAKE, N.J., Dec. 23, 2010 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE :PRX ) announced today that Chairman, President and Chief Executive Officer, Patrick G. LePore, will present an overview of the company's growth strategy and its three-year financial outlook on Wednesday, January 12, 2011 from 8:30 to 9:00am PST (11:30am to 12:00pm EST) at the 29th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel, San Francisco, California.
This event will be broadcast live on Par's website www.parpharm.com and the conference website at http://jpmorgan.metameetings.com/webcasts/healthcare11/directlink?ticker=PRX
An archived version of the presentation will available for 90 days after the live presentation.
About Par Pharmaceutical Companies
Par Pharmaceutical Companies, Inc. is a U.S.-based specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets higher-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press releases and other company information, visit www.parpharm.com.
SOURCE Par Pharmaceutical Companies, Inc.